Medical Advisory Board////////////////////////

Our Medical Advisory Board is comprised of distinguished scientists and leaders of biomedical research institutions who constitute the principal advisory group for the scientific program of the company.

Eric A. Klein, MD

Eric A. Klein, MD, is the Chairman of the Glickman Urological & Kidney Institute and a staff member in the Taussig Cancer Institute at Cleveland Clinic. His clinical interests are cancers of the prostate,  testis and kidney.  For several years, including the current edition, Dr. Klein is listed in Best Doctors in America.

Board-certified in urology, Dr. Klein is a frequent lecturer and visiting professor at numerous national and international universities. He was the National Medical Study Coordinator for the National Cancer Institute sponsored Selenium and Vitamin E Cancer Prevention Trial (SELECT). Dr. Klein is the editor of Urology and has been the recipient of numerous awards from the American Cancer Society, the University of Pittsburgh School of Medicine, and the Cleveland Clinic.

Dr. Klein received his medical degree from University of Pittsburgh School of Medicine in Pennsylvania. He completed his residency in urology at Cleveland Clinic and a fellowship in urology at the Memorial Sloan Kettering Cancer Center in New York.

H. Barton Grossman, MD, FACS

Part-time Professor in the Dept. of Urology M.D. Anderson Cancer Center. Dr. Grossman was awarded his medical degree from Temple University. He then completed a residency in Urology at the University of Michigan. He obtained additional training in a clinical and research fellowship at Memorial Sloan-Kettering Cancer Center and returned to the University of Michigan where he rose to Professor.

In 1994, he joined the faculty of The University of Texas M. D. Anderson Cancer Center where he is Professor and Deputy Chairman of the Department of Urology. He also holds the W. A. ?Tex? and Deborah Moncrief, Jr. Distinguished Chair in Urology.

Dr. Grossman has numerous publications and continues to have an active research laboratory.

Maria J. Ribal MD PhD

Maria J. Ribal received her medical degree in 1994, followed by her PhD in 2002, both at the University of Barcelona. After 5 years residency in urology at the University Hospital Clinic in Barcelona, she became a member of the Spanish Board of Urology in 1999.

She did a research Fellowship with an Investigation Grant at the Hospital Clinic in 2000-2001. She attended as Visiting Clinician at Mayo Clinic in Rochester (USA) in 2002. Fellow in Laparoscopic Surgery at the University College London Hospital (UCLH) from June till December 2006.

She has been member at the Oncology Unit of the Department of Urology at Fundacio Puigvert (2002-2005). Since February 2005, she is member of the Department of Urology at the University Hospital Clinic of Barcelona. Currently, she is Associated Professor of Surgery at the University of Barcelona. From December 2011 she is the Head of the Multidisciplinary Unit of Uro- Oncology at Hospital Clinic.

Her main interests include urologic oncology, major oncologic surgery, laparoscopic surgery and transplantation and genetic research of urological tumors.

She is the author of 53 national and 22 international publications, 10 book chapters, and 195 invited lectures at conferences and courses.

She is an active member of European Association of Urology: Member of the Muscle Invasive and Metastatic Bladder Cancer Guidelines Group of the European Association of Urology (EAU) since 2006, Member of the ESUT Working group from European Association of Urology since 2010. Board member of the EUSP Office of the European Association of Urology since April 2012.

In 2009, during the EAU Annual Meeting held in Stockholm, she received the Crystal Matula award.